A Randomized Controlled Trial Testing the Effect of the Youth Mindful Awareness Program on Negative Affect (YMAP2).
Targeting Negative Affect Through Mindfulness Training in Youth at Risk for Internalizing Problems (R33)
Vanderbilt University
360 participants
Apr 1, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this randomized clinical trial is to compare the effects of an online mindfulness program to an active supportive comparison condition and a no-intervention control group on reducing and preventing mood and anxiety symptoms in at-risk youth. Youth who are high on trait negative affect will be randomized to one of the three conditions. The primary outcomes of interest are reductions in momentary negative affect and internalizing problems in adolescents ages 12 to 17 years old. All participants will be evaluated prior to being randomized, after the 9-session intervention period, and at a 6-month follow-up. The first hypothesis is that the mindfulness intervention will predict decreases in stressor-reactive momentary negative affect and internalizing symptoms. The second hypothesis is that changes in momentary negative affect will partially account for the effects of the mindfulness intervention on internalizing symptoms.
Eligibility
Inclusion Criteria4
- Ages 12, 13, 14, 15, 16, 17
- Parental Consent
- Participant Assent
- Live in Illinois, California, or Tennessee
Exclusion Criteria6
- current diagnosis of an anxiety or depressive disorder with significant clinical impairment
- current alcohol or substance use disorder
- current serious suicidal ideation or behavior
- lifetime diagnosis of bipolar disorder, schizophrenia, autism, conduct disorder, or developmental delay
- reading level below 4th grade
- not English speaking at a level that would allow them to participate in the intervention and assessments
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Online, coached mindfulness training program
Remote meetings with a supportive coach
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06526052